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A B S T R A C T
Worldwide there is no general attitude on optimal surgical procedure in treatment of primary non-ampullary ade-
nocarcinoma of duodenum, especially for early stage of duodenal cancer. Some authors prefer local excision and segmen-
tal resection while others rather perform duodenopancreatic resection, even in the case of early stage of duodenal cancer
with aim to avoid tumor recurrence. In this paper we present a rare clinical course of a 60-year-old male patient with an
endoscopically and pathohistologically proven early stage duodenal cancer that was treated by wide local excision. Three
years after operation, control endoscopy showed »flat« polyp in the duodenum and radical duodenopancreatic resection
was performed. Pathohistological examination of resected specimen showed cancer that had spread throughout the duo-
denal wall with metastases in the regional lymph nodes. According to our findings and literature review we gave some
direction concerning the optimal diagnostic and surgical procedure for this rare tumor.
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Introduction
Although the small intestine accounts for 75% of the
length and 90% of the surface area of the gastrointestinal
(GI) tract, small-bowel cancers are rare and account for
only 1.4% of gastrointestinal neoplasms. The incidence of
small-bowel cancer was reported in 1994 as 1.6 per
100,000 of the population1,2.
Compared to other GI tumors, our knowledge of natu-
ral history and the prognosis of patients with small bowel
tumors is limited because of the fact that these neo-
plasms are relatively rare and there are several different
tumor types.
It has been estimated that 40% of small bowel tumors
are adenocarcinomas, 40% are carcinoids, 15% are sarco-
mas (GI stromal tumors) and less than 5% are lym-
phomas3. Small bowel adenocarcinomas account for 2%
of gastrointestinal tumors and 1% of gastrointestinal
deaths4.
The duodenum consists only 8% of the small bowel
length5 although it is the site of one-half to two thirds of
all small bowel adenocarcinomas. It is possible that the
duodenum is at highest risk because it is the first site to
be exposed to a variety of potentially injurious agents,
both those consumed and those produced within the GI
tract; bile, pancreatic secretions, stomach acid.
Primary adenocarcinoma of the duodenum, excluding
that of the ampulla of Vater, is an uncommon condition.
It represents about 0.35% of all malignant neoplasms of
the gastrointestinal tract and 33%–45% of malignant
neoplasms of the small intestine6–8.
In the studies that were published before 1990 be-
cause of high morbidity and mortality after Whipple pro-
cedure, local excision was preferred but it has resulted in
low survival rate: 0–50%9–11. On the other hand when
duodenopancreatic resection (DP, Whipple procedure) was
performed survival rate of 40–60% had been report-
ed12,13. This increase in survival rate can be explained by
radical lymphadenectomy in radical surgical procedure.
Some authors favorite DP for all patients with ade-
nocarcinoma of the duodenum including those tumors lo-
cated in the third and fourth portion of the duodenum, to
ensure adequate en block resection and wide lympha-
denectomy6,14 while other groups advocate the use of DP
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for proximal duodenal carcinomas – first and second seg-
ment, but segmental resection for cancers of the third
and fourth portion which secures negative resection
margins and local lymphadenectomy. Their theory is
based on the fact that lymphatic pathways of the distal
two duodenal portions flow into the small bowel me-
sentery, not into the pancreaticoduodenal lymphatic re-
gion that is removed by DP procedure9,15,16.
Case Report
Sixty years old male patient has been hospitalized in
Surgery Clinic »Sestre milosrdnice« because of recurrent
tumor of the second duodenal part. First symptoms ap-
peared three years ago and were presented with obscure
pain in upper abdomen – epigastrium, right upper quad-
rant pain, and progressive weight loss (17 kg in 3 months),
without nausea or vomiting. Patient’s past history did
not include risk factors for duodenal cancer. He was a
healthy man, a non-smoker and wasn’t consuming alco-
hol. Thus, radiography by using the barium swallow en-
ema was performed and fill up defect in the descending
portion of duodenum was seen (Figure 1). Endoscopic
and pathohistologic examination revealed an adenoma
on the anterior wall of the descending duodenal segment
that measured 2 cm in diameter. Therefore, operation in
general endotracheal anesthesia was performed. At sur-
gical exploration, an intraluminal duodenal palpable mass
was found, with no sings of disseminated disease. Duo-
denotomy and polypectomy with partial excision of ante-
rior duodenal wall was performed. In the same act,
Heller’s operation due to achalasia was performed. Oper-
ation and postoperative period passed without any com-
plications and the patient was discharged from hospital
at eleventh postoperative day.
Macroscopically, a broad base polypoid tumor in the
resected duodenum that measured 4x2.5x1 cm was fo-
und. Histological section of the tumor showed invasive
adenocarcinoma of the duodenum that was made of atyp-
ical glandular formations covered with atypical cylindri-
cal epithelial cells. Tumor tissue infiltrated submucousa,
but did not infiltrate the muscularis propria layer. Resec-
tion lines were free of tumor. Tumor was classified as the
T1NxMx according to American Joint Committee on
Cancer (AJCC) grading classification for malignant neo-
plasm of the small intestine that is based on the extent of
local spread of the tumor, lymph node status and visceral
metastasis17 (Figure 2).
With regard to the pathohystological findings, fre-
quent control endoscopy examinations of gastrointesti-
nal tract were performed with the aim to detect possible
early tumor recurrence. Frequency of following up was
every three months at first two years and after that every
six months. Thus, on routine control duodenoscopy,
three years after the first operation, duodenal »flat«
polypus was found. Pathohistological examination of ten
biopsy specimens that measured from 0.1 to 0.2 cm in di-
ameter, showed atypical glandular tumor formation cov-
ered with clusters of necrotic and atypical, polymorphic
cells, with inflammatory reaction in surrounding stromal
tissue.
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Fig. 1. Barium swallow enema radiography shows the fill up de-
fect in the descending portion of duodenum measuring the 2 to
2.5 cm in the diameter.
Fig. 2. Invasive adenocarcinoma of the duodenum that was made
of atypical glandular formations covered with atypical cylindri-
cal epithelial cells. Tumour tissue infiltrated submucousa, but
did not infiltrate the muscularis propria layer.
Endoscopic ultrasonography showed tumor in the de-
scending duodenal portion measuring 3x4 cm that had
spread throughout the duodenal wall with enlargement
of local lymph nodes (Figure 3). All laboratory findings
were normal including the serum tumor markers: CA19-
9: 8.7 U/mL (normal range < 37 U/mL), AFP: 13.4 U/mL
(normal range 0.8–8.8 U/mL), CEA: 0.6 ng/mL (normal
range 0–5 ng/mL).
Therefore, cephalic pancreatoduodenectomy with dis-
section of the respective regional lymph nodes (D2) was
performed, followed by pancreaticogastrostomy. Surgical
examination of abdominal cavity did not reveal any signs
of visible malignant dissemination.
Macroscopic examination of the resected specimen
made of stomach that measured 6x6x2 cm, duodenum
with part of small intestine sized 28 cm and part of pan-
creas that measured 6x5x3 cm showed fungoid formation
that protruded into the duodenal cavity. The formation
was ulcerated, white colored, soft in consistency and
measured 5 cm in diameter. Microscopically, tumor was
formed of glandular formations with atypical epithelial
cells that produced large amount of mucus. Tumor ex-
tended through all duodenal layers but it didn’t infiltrate
pancreas or papilla of Vater. In the surrounding fat tissue
of the pancreas, four lymphatic nodes were found (less
than 1 cm in diameter). One of them was infiltrated with
the tumor that broke its capsule. No tumor was found in
any of four perigastric lymph nodes. Thus tumor was
classified as T2N1M0, G2.
Postoperative period passed without complications
and the patient was discharged from hospital in good
condition. In June 2004 patient received the last out of
six cycles of chemotherapy by the following regimen:
Leukovorin 40 mg + 5-FU 850 mg intravenously during
5 days. Between each cycle there was a pause of three
weeks.
Control endoscopy, computed tomography and serum
tumor markers level didn’t reveal any signs of tumor re-
currence.
Discussion
The duodenum is the shortest, widest, and the most
fixed part of the small intestine. It is divided into four
parts; a superior or first part, a descending or second
part, a horizontal or third part and an ascending or
fourth part of duodenum18. Duodenal carcinoma usually
develops in the descending segment while carcinoma of
the horizontal and ascending segment are extremely
rare7. Causative factors of duodenal cancer have not been
clearly identified yet, but there are several well known
potential factors: familiar polyposis (2–4.5% of all cases
of duodenal adenocarcinoma would be expected to have
arisen in FAP patients)4, Gardner syndrome, duodenal
polyps without a predisposing family history, duodenal
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Fig. 4. Macroscopic (a) andandmicroscopic (b) specimen showed that recurrent tumor was formed of glandular formations with atypical
epithelial cells that produced large amounts of mucus. Tumor extended through all duodenal layers but it didn’t infiltrate pancreas or
papilla of Vater.
b)a)
Fig. 3. Endoscopic ultrasonography shows a tumor measuring
3x4 cm in the descending duodenal portion that spreads through-
out the duodenal wall and enlarged regional lymph nodes.
adenomas19–21, and villous tumors (up to 50% of cases
may harbor carcinoma at the time of diagnosis)22,23. Pa-
tients with duodenal adenocarcinoma tend to have non-
specific signs and symptoms like abdominal pain, weight
loss, nausea, vomiting, obstruction and chronic GI bleed-
ing. In patients with upper abdominal complaints, ultra-
sonography is widely used as the first imaging procedure,
together with the endoscopy examinations of the stom-
ach and duodenum. The ultrasonographic appearance of
duodenal carcinoma has been described in a few stu-
dies24,25. Careful observations during routine abdominal
ultrasonography may be helpful in the proper localiza-
tion and diagnosis of a duodenal tumor, although duode-
nal endoscopy with biopsy is essential to confirm the di-
agnosis. Endoscopic ultrasound is a relatively new and
very useful method for making the diagnosis and the
staging of these tumors. Other methods are upper gas-
trointestinal tract radiography or barium swallow test
and CT with aim to assess extent of disease. Dudiak et
al26 in his study evaluated the CT findings in patients
with duodenal cancers and showed that duodenal adeno-
carcinomas (n=15) frequently appear as solitary proximal
small bowel masses rarely greater than 8 cm in diameter.
Ulceration was seen in one third of all adenocarcinomas
and lymphadenopathy was seen in one half of tumors26.
In summary, diagnosis of duodenal tumor is the most re-
liable using endoscopy and biopsy, whereas endoscopic
ultrasonography and CT are best for assessing the tumor
extension.
Gastrointestinal flat adenoma is a rare disorder, first
described by Muto et al. in 198527 as adenomas that are
characteristically elevated and plaque-like, with a red-
dish surface and sometimes a central depression. There-
fore, these lesions are difficult to detect using standard
endoscopy techniques, and special techniques using dyes
to identify flat gastrointestinal adenomas are required28,29.
Flat adenomas are associated with higher frequency of
aneuploidy compared to the polypoid adenomas30. Also,
flat adenomas were 10 times more likely to contain
high-grade dysplasia than polypoid adenomas and there
is some evidence to suggest that flat lesions have a higher
malignant potential than the polypoid type31,32,33.
Surgical methods that are widely used in treatment of
duodenal carcinoma are: endoscopic excision, local excision,
segmental resection, pancreaticoduodenectomy (Whipple
procedure – PD) and pylorus-preserving pancreaticoduo-
denectomy. The most important prognostic factors in pa-
tients with duodenal carcinoma are resectability, tumor
diameter, histological grading, transmural invasion and
presence of distant metastasis34,35. Lymph node metas-
tases are significantly related to the occurrence of dis-
tant metastases36–38. 5-year survival rate was 43% after
performing PD with lymphadenectomy in the patients
with a positive node status37,39. One of the main prognos-
tic factors is advanced tumor stage. Thus, in the cases of
pancreatic invasion, preoperative chemoradiotherapy plus
extended lymphadenectomy is strongly recommended as
the most promising approach40,41.
There are many controversies according to the opti-
mal surgical procedure in the cases of early duodenal
cancers and multiple studies have failed to demonstrate
a survival difference between local duodenal resection
and PD15,42–44. Alwmark et al11 performed a segmental
duodenectomy more preferentially (62%) and showed
that regional recurrence was a common cause of cancer
death. It can be explained by residual cancer cells in the
regional lymph nodes or pancreatic parenchyma when
the segmental duodenectomy is used. Delcore et al.12 in
his study showed that 5-year survival rate after PD for
this cancer was 52% whereas there was no 2-year survi-
vor after segmental duodenectomy. However, recent stu-
dies show that PD should not longer be considered the
appropriate therapy for primary adenocarcinoma of the
third and fourth portions of the duodenum, because duo-
denal segmentectomy is associated with negligible rates
of morbidity and mortality, while allowing for satisfac-
tory margin clearance and adequate lymphadenecto-
my15,29,46,47. On the other hand, overall hospital mortality
after PD is 3–12.5%45 while the 5-year survival rate is
100% for patients with stage I, 52% for stage II and 45%
for stage III tumors15,35.
In conclusion, this case report shows that transduo-
denal resection is an inadequate operation even for early
stage of duodenal carcinoma because this procedure car-
ries a significant risk for recurrence. This is supported by
studies in which transduodenal local excision of villous
adenomas leads to 30% local failure29,48. It is also worth
noting that standard endoscopy examination failed to de-
tect disease recurrence in early tumor stage due to the
flat nature of recurred adenoma in our patients. There-
fore, we believe that PD is the best surgical procedure for
all stages of duodenal cancers in first and second part of
duodenum especially in patients that are in good general
medical condition. In old and chronically ill patients
(ASA score III or IV), in whom the diagnosis of early duo-
denal cancer (T1) is established and confirmed by endo-
scopic ultrasonography and CT, but at high operative
risk for Whipple procedure, local excisional procedure
can be performed. For these patients we proposed fol-
low-up every three moths and each time endoscopic
ultrasonography or die endoscopy examination has to be
performed with the aim to identify possible tumor recur-
rence. Standard endoscopy and blood tumor markers
measurement (CEA and CA19-9) are not helpful meth-
ods for early tumor recurrence detection.
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LOKALNI RECIDIV PRIMARNOG NEAMPULARNOG ADENOKARCINOMA DUODENUMA
NAKON KIRUR[KOG ZAHVATA – PRIKAZ SLU^AJA I PREGLED LITERATURE
S A @ E T A K
U svijetu ne postoji op}eprihva}eno mi{ljenje glede optimalnog kirur{kog zahvata u lije~enju primarnog neampu-
larnog adenokarcinoma duodenuma, osobito u slu~ajevima ranog stadija. Neki autori preferiraju lokalnu eksciziju i
segmentalnu resekciju duodenuma, dok drugi radije pribjegavaju duodenopankreati~noj resekciji, ~ak i u slu~ajevima
ranog stadija duodenalnog karcinoma s ciljem da sprije~e nastanak recidiva tumora. U ovom radu iznosimo klini~ki
tijek bolesti kod 60 godina starog bolesnika, kod kojega je endoskopski i patohistolo{ki dokazan po~etni karcinom duo-
denuma te je primarno kirur{ki lije~en {irokom lokalnom ekscizijom tumora. Tri godine nakon operacije, na kontrolnoj
endoskopiji na|en je ravni, »flat« polip duodenuma radi ~ega je u~injen radikalni kirur{ki zahvat; resekcija duodenuma
i gu{tera~e. Patohistolo{ka analiza reseciranog tkiva pokazala je da se radi o adenokarcinomu koji se pro{irio kroz sve
slojeve duodenuma te metastazirao u regionalne limfne ~vorove. Na temelju na{eg slu~aja te pregledom svjetske litera-
ture, u ovom radu donosimo smjernice koje se odnose na dijagnostiku i optimalno kirur{ko lije~enje ove rijetke bolesti.
